UNIVERSITY OF MINNESOTA | Amyloidosis Program
UNIVERSITY OF MINNESOTA | Amyloidosis Program
"Multiple Myeloma - The Current Treatment Landscape and Mechanisms of Resistance" Aimee Merino, MD PhD; July 6, 2023
"Complement-Mediated Kidney Diseases: Pathophysiology and Treatment Paradigm in 2023" Nattawat Klomjit, MD, FASN; February 9, 2023
"Cardiac Amyloidosis" Valmiki Maharaj, MD; August 11, 2022
“Heart Rate - Pathophysiology and Therapeutic Use” Markus Meyer, MD; November 19, 2020
"How I approach HFpEF in 2025" Valmiki Maharaj, MD; May 1, 2025 - 10-15% of HFpEF patients have undiagnosed amyloid!
"Non-immunoglobulin mediated Renal Amyloidosis: an update" Sabine Karam, MD; January 16, 2025
"AA Amyloidosis: Presentation, Management and Current Therapeutic Options" Sabine Karam, MD; September 22, 2022
Amyloidosis Foundation: https://amyloidosis.org/
Amyloidosis Support Groups: https://www.amyloidosissupport.org
One Amyloid Voice: https://www.oneamyloidosisvoice.com
Mackenzie’s Mission: https://mm713.org
Amyloid Research Consortium: https://arci.org